ABG
PMN icon

Ally Bridge Group’s ProMIS Neurosciences PMN Stock Holding History

Ally Bridge Group’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.16M Buy
620,319
+206,100
+50% +$2.24M 7.22% 4
2026
Q1 		$5.26M Buy
414,219
+164,880
+66% +$2.46M 4.25% 10
2025
Q4 		$1.7M Sell
249,339
-1
-0% -$10 1.77% 18
2025
Q3 		$2.65M Buy
249,340
+195,963
+367% +$2.71M 1.61% 19
2025
Q2 		$646K Sell
53,377
-6,011
-10% -$82K 0.54% 24
2025
Q1 		$1.03M Sell
59,388
-4,316
-7% -$91.6K 0.93% 26
2024
Q4 		$1.51M Hold
63,704
– – 1.29% 29
2024
Q3 		$1.99M Buy
63,704
+21,321
+50% +$796K 1.07% 29
2024
Q2 		$1.59M Hold
42,383
– – 0.95% 25
2024
Q1 		$2.02M Sell
42,383
-284
-0.7% -$14.1K 1.13% 21
2023
Q4 		$1.23M Buy
42,667
+21,390
+101% +$800K 0.73% 20
2023
Q3 		$1.05M Buy
+21,277
New +$1.38M 1.24% 18

Other funds holding PMN

JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Ally Bridge Group's PMN Position: Q2 2026 in Review

Ally Bridge Group increased its ProMIS Neurosciences (PMN) stake by 50% in Q2 2026, buying an estimated $2.24M and bringing the position to 620,319 shares worth $8.16M. The position accounts for 7.22% of the portfolio, ranked #4.

Ally Bridge Group first reported a position in PMN in Q3 2023 and has held it in 12 quarters since. 27 funds tracked by Wall St. Rank hold PMN as of Q2 2026.

  • Ally Bridge Group held 620,319 shares of ProMIS Neurosciences worth $8.16M as of Q2 2026.
  • Ally Bridge Group bought 206,100 ProMIS Neurosciences shares in Q2 2026, an estimated $2.24M.
  • ProMIS Neurosciences made up 7.22% of Ally Bridge Group's portfolio in Q2 2026, its #4 holding.
  • Ally Bridge Group first reported a position in ProMIS Neurosciences in Q3 2023 and has held it in 12 quarters since.
  • 27 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q2 2026.

Based on Ally Bridge Group's 13F filing for Q2 2026, filed 14 Aug 2026.